Nevertheless, the early occurrence of IDH mutations during gliomagenesis means that their expression in IDH-mutated gliomas should be homogenous among tumor cells, making them particularly promising targets for tumor imaging. This evidence concerns the gene IDH2 and central nervous system cancer.